Abstract

Sorafenib Capsules for Pediatric Use

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2019 - Volume 23, Number 5

Page(s): 411

Download in electronic PDF format for $75
  • Sorafenib Capsules for Pediatric Use Page 1

Abstract

A formulation for preparing Sorafenib Capsules for Pediatric Use. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • sorafenib
  • formulation
  • children
  • kinase inhibitor
  • targeted cancer therapy

Related Categories

  • CANCER AND AIDS
  • FORMULATIONS
  • PEDIATRICS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2019
Pg. 411
Sorafenib Capsules for Pediatric Use
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 420
Sorafenib 20-mg/mL in Oil Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2001
Pg. 6-8
Pediatric Compounding: Coloring Outside the Lines
Author(s): Preckshot John
May/Jun 2007
Pg. 220-225
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
Mar/Apr 2011
Pg. 124-128
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease
Author(s): Corsini Lindsay, Williams LaVonn A
Nov/Dec 2016
Pg. 510
Imatinib 40-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2001
Pg. 9-12
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients
Author(s): Schotik Debora
Mar/Apr 1997
Pg. 84-86
Compounding for the Pediatric Patient
Author(s): Allen Loyd V Jr
Jan/Feb 2007
Pg. 5-8
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1
Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
Jul/Aug 1999
Pg. 274-276
Extemporaneous Formulations in Pediatric Patients
Author(s): Nahata Milap C
Jul/Aug 1999
Pg. 291-294
The Basics of Compounding: Compounding Special Capsules
Author(s): Allen Loyd V Jr
Sep/Oct 2016
Pg. 359-364
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Author(s): Deleruyelle Laura J
Mar/Apr 2010
Pg. 100-104
Hormonal Influences in Prostate Cancer: An Update of a Complex Subject
Author(s): Biundo Bruce
May/Jun 2005
Pg. 195-198
Compounding Antiangiogenic Cancer Therapy for Animals
Author(s): Davidson Gigi S
Jan/Feb 2007
Pg. 17-19
Pediatric Oral Formulations: A Continual Challenge
Author(s): Hurtado Josephine, Moffett Brady S
Nov/Dec 2005
Pg. 410
Prescription: Pediatric Formulation Initiatives
Author(s): Allen Loyd V Jr
Nov/Dec 2005
Pg. 456-461
Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions
Author(s): Fonseca Simonne C
Jan/Feb 2009
Pg. 6-12
Compounding for Pediatric Patients: Case Reports and Formulations
Author(s): Mixon William, Angelle Patricea, Yoch Douglas
Jul/Aug 2000
Pg. 257-260
Surviving Cancer - How the Compounding Pharmacist Can Help
Author(s): Maddox Suzan
Nov/Dec 2005
Pg. 423-431
Compounding for a Pediatric Hospital
Author(s): McElhiney Linda F